Evaluating and Deploying Covid-19 Vaccines - The Importance of Transparency, Scientific Integrity, and Public Trust

N Engl J Med. 2020 Oct 29;383(18):1703-1705. doi: 10.1056/NEJMp2026393. Epub 2020 Sep 23.

Author

Jason L Schwartz¹

Affiliation

¹ From the Department of Health Policy and Management, Yale School of Public Health, and the Section of the History of Medicine, Yale School of Medicine, New Haven, CT.

PMID: 32966716
DOI: 10.1056/NEJMp2026393

No abstract available

MeSH terms

Advisory Committees*
Betacoronavirus
COVID-19
COVID-19 Vaccines
Centers for Disease Control and Prevention, U.S.
Coronavirus Infections / prevention & control*
Humans
Information Dissemination
Pandemics / prevention & control*
Pneumonia, Viral / prevention & control*
SARS-CoV-2
Safety
Trust
United States
United States Food and Drug Administration*
Vaccination / psychology
Viral Vaccines / administration & dosage*
Viral Vaccines / standards*

Substances

COVID-19 Vaccines
Viral Vaccines